Nephroprotective Effects of the Dual <scp>GCGR</scp> / <scp>GLP</scp> ‐ <scp>1R</scp> Agonist Survodutide in Hypertension‐Accelerated Diabetic Kidney Disease

Alexander Hamilton, Louise Thisted, Maria Ougaard, Max Hahn, Kasper Andersen, Johanna Perens, Robert Augustin, Besnik Bajrami, Wolfgang Rist, Michael Christensen, Henrik H. Hansen, Thomas Klein

Open source

DOI: 10.1111/dom.71387
Published: 2026-10-01
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.71387,
  title = {Nephroprotective Effects of the Dual
                    <scp>GCGR</scp>
                    /
                    <scp>GLP</scp>
                    ‐
                    <scp>1R</scp>
                    Agonist Survodutide in Hypertension‐Accelerated Diabetic Kidney Disease},
  author = {Alexander Hamilton and Louise Thisted and Maria Ougaard and Max Hahn and Kasper Andersen and Johanna Perens and Robert Augustin and Besnik Bajrami and Wolfgang Rist and Michael Christensen and Henrik H. Hansen and Thomas Klein},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71387},
  url = {https://doi.org/10.1111/dom.71387}
}

RIS

TY  - JOUR
TI  - Nephroprotective Effects of the Dual
                    <scp>GCGR</scp>
                    /
                    <scp>GLP</scp>
                    ‐
                    <scp>1R</scp>
                    Agonist Survodutide in Hypertension‐Accelerated Diabetic Kidney Disease
AU  - Alexander Hamilton
AU  - Louise Thisted
AU  - Maria Ougaard
AU  - Max Hahn
AU  - Kasper Andersen
AU  - Johanna Perens
AU  - Robert Augustin
AU  - Besnik Bajrami
AU  - Wolfgang Rist
AU  - Michael Christensen
AU  - Henrik H. Hansen
AU  - Thomas Klein
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71387
UR  - https://doi.org/10.1111/dom.71387
ER  -

APA

Hamilton, A., Thisted, L., Ougaard, M., Hahn, M., Andersen, K., Perens, J., Augustin, R., Bajrami, B., Rist, W., Christensen, M., Hansen, H. H., & Klein, T. (2026). Nephroprotective Effects of the Dual <scp>GCGR</scp> / <scp>GLP</scp> ‐ <scp>1R</scp> Agonist Survodutide in Hypertension‐Accelerated Diabetic Kidney Disease. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71387

Source records

crossref · retrieved 2026-11-10T11:27:39.572Z